Amalgamated Financial’s iRadimed IRMD Stock Holding History

Amalgamated Financial’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$46K	Buy	+1,036	New	+$47.9K	﹤0.01%	2471

Other funds holding IRMD

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

RCMC

RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

RCG

Resource Consulting Group Orlando, Florida $584M AUM 15.38% 1-Year Est. Return

Amalgamated Financial's IRMD Position: Q1 2022 in Review

Amalgamated Financial opened a new position in iRadimed (IRMD) in Q1 2022: 1,036 shares worth $46K. The stake represents ﹤0.01% of the portfolio and ranks #2471 among its holdings.

104 funds tracked by Wall St. Rank hold IRMD as of Q1 2022.

Amalgamated Financial held 1,036 shares of iRadimed worth $46K as of Q1 2022.
iRadimed was a new Amalgamated Financial position in Q1 2022.
iRadimed made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2471 holding.
104 funds tracked by Wall St. Rank held iRadimed as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.